Nicoletta D'Alessandris

Medicine and Dentistry

1. Systematic Review 100%
2. Meta-Analysis 71%
3. Endometrium Carcinoma 69%
4. Endometrioid Carcinoma 69%
5. DNA Mismatch Repair 46%
6. Protein P53 42%
7. Plasma Cell 33%
8. Tumor Regression 33%
9. Clear Cell 33%
10. Chemoradiotherapy 33%
11. Differential Diagnosis 33%
12. Cervical Cancer 33%
13. Female Genital Tract Cancer 33%
14. Programmed Death-Ligand 1 33%
15. Inpatient 33%
16. Endometritis 33%
17. Myocardial Disease 33%
18. Heart Muscle Biopsy 33%
19. Myocarditis 33%
20. Diagnosis 28%
21. Nonischemic Cardiomyopathy 25%
22. Clear Cell Carcinoma 19%
23. Overall Survival 18%
24. Risk Stratification 16%
25. Cardiac Magnetic Resonance Imaging 16%
26. Cancer Cell 13%
27. Disease Free Survival 13%
28. Proportional Hazards Model 11%
29. Mismatch Repair Protein PMS2 11%
30. The Cancer Genome Atlas 11%
31. Hazard Ratio 10%
32. Neoplasm 8%
33. Immune Checkpoint Inhibitor 8%
34. Cancer 8%
35. Right Ventricle 8%
36. QRS Interval 8%
37. Multivariate Analysis 8%
38. Histology 8%
39. Genetic Screening 8%
40. Clinical Imaging 8%
41. Heart Left Ventricle Ejection Fraction 8%
42. Sustained Ventricular Tachycardia 8%
43. Left Ventricle 8%
44. Spontaneous Abortion 7%
45. Protein Expression 6%
46. Prognostic Factor 6%
47. Fibrosis 6%
48. Scoring System 6%
49. Adjuvant Therapy 6%
50. Survival Rate 6%